CP-17
CP-17 is a potent and selective IDH2/R140Q inhibitor with an IC50 of 40.75 nM. CP-17 exhibits excellent selectivity of >55-fold against the wild-type IDH2. CP-17 exhibits robust D-2-HG suppression activity in TF-1 (IDH2/R140Q) cells and reverses the cellular differentiation block induced by the R140Q mutation. CP-17 can be used for acute myeloid leukemia (AML) research[1].
Product Specifications
CAS Number
1111233-06-7
UNSPSC
12352005
Target
Isocitrate Dehydrogenase (IDH)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
O=C(NC1=CC(Cl)=CC=C1C)NC2=CC(NC(C3=CC=CC=C3)=O)=CC=C2N4CCCC4
Molecular Formula
C25H25ClN4O2
Molecular Weight
448.94
References & Citations
[1]Chen J, et al. Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells. Cell Commun Signal. 2020 Apr 3;18 (1) :55.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IDH2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A5010-20 10 mg
5-Azido-5-deoxy-3,4-di-O-acetyl-1,2-O-isopropylidene-b-D-fructose
Sign In for Pricing
View Details 
RPU57251-01 50 µg
Recombinant Rat Adrenergic Receptor Beta 2 (ADRb2)
Sign In for Pricing
View Details